BLFE OTC
BioLife Sciences Inc.
1W: -99.0%
1M: -99.0%
3M: -99.0%
YTD: -99.0%
1Y: +0.0%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$412K
+0.0% ▲
Gross Profit
-$985K
+0.0% ▲
Operating Income
-$1M
+0.0% ▲
Net Income
-$1M
-111716.6% ▼
EPS (Diluted)
$-0.02
-24400.0% ▼
EBITDA
-$1M
-809.0% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $412K |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $1M |
| Gross Profit | $0 | $0 | $0 | $0 | -$985K |
| Gross Margin | — | — | — | — | -239.3% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $12K | $329K | $42K | $0 | $259K |
| Operating Expenses | $12K | $329K | $42K | $0 | $259K |
| Operating Income | -$12K | -$329K | -$42K | $0 | -$1M |
| Operating Margin | — | — | — | — | -302.2% |
| Interest Expense | $7K | $11K | $10K | $0 | $49K |
| Income Before Tax | -$19K | -$340K | -$53K | -$1K | -$1M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$19K | -$340K | -$53K | -$1K | -$1M |
| Net Margin | — | — | — | — | -308.0% |
| EPS (Diluted) | $-0.05 | $-0.08 | $-0.00 | $-0.00 | $-0.02 |
| EBITDA | -$12K | -$329K | -$42K | $172K | -$1M |
| Shares Outstanding | 421263 | 4M | 19M | 19M | 52M |